Multiple rodent studies have shown that the depletion of ASK1 action throughout the body or selectively in adipose tissues leads to the amelioration of HFD-induced insulin resistance [53–55]; however, one human study suggests that ASK1 expression in skeletal muscle positively correlates with in vivo insulin action [56]. This evidence concerns the gene MAP3K5 and Insulin resistance.